VXRT News and Press, Vaxart Inc. From 10/20/21

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Covid-19 cases are decreasing across the U.S. and parts of Europe, but for the nations still struggling to gain access to vaccines, a recent setback in production means further bad news. Maryland-based Novavax (NASDAQ: ...

There are a handful of companies that dominate the coronavirus vaccine market. The two leaders -- Pfizer and Moderna -- expect to generate a combined $55.5 billion in sales this year. Is there any room left in this space for newcomers? The answer is a resounding yes. First, vaccines...

Vaxart (NASDAQ: VXRT) soared to stardom when its shares advanced 1,500% last year. Why the excitement? The biotech company is developing a coronavirus-vaccine candidate in pill form. Investors realized such a product could win over those who cringe at the thought of needles. ...

New Duke University-led Study Shows That Vaxart's Oral COVID-19 Vaccine Candidate Reduces Airborne Transmission of SARS-CoV-2 Infection in Animal Model Data published in bioRxiv confirmed previous findings suggesting mucosal vaccines could reduce transmission of airborne viruses...

Shares of the developmental-stage biotech Vaxart (NASDAQ: VXRT) sank by 11.5% last month, according to data provided by S&P Global Market Intelligence . The biotech's stock has been sliding hard over the past month and half for two related reasons: Image source: Getty Im...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips When Merck (NYSE: MRK ) announced last week that it had an inexpensive antiviral oral drug to treat Covid-19, Vaxart (NASDAQ: VXRT ) plunged by almost 10%. For much of the year, VXRT stock moved nowhere. Bears hav...

Vaxart Begins Recruiting in Global Phase II COVID-19 Oral Tablet Vaccine Clinical Trial Start of US Phase II of S-Only Vaccine Candidate Expected Later This Month Ex-US Clinical Trials to Begin Later This Year with India Study PR Newswire SOUTH SAN FRA...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, vaccine stocks are once again in focus for investors. However, this time, the news isn’t as good as investors might hope to see. Source: shutterstock.com/PhotobyTawat Indeed, vaccine stocks such as ...

Good news for some companies often means bad news for others. That's what we're seeing Friday as the stocks of several COVID-19 vaccine makers sank following the announcement by Merck (NYSE: MRK) and Ridgeback Biotherapeutics of positive results from a late-stage study of an oral CO...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Based in California, Vaxart  (NASDAQ: VXRT ) is a biotech company known for making vaccines. But there’s an unusual, differentiating angle here: its vaccines are orally administered. This is certainly inter...